GEN Exclusives

More »

GEN News Highlights

More »
Dec 19, 2006

GSK Procures 1,000 Illumina BeadChips for Whole-Genome Association Studies

  • GlaxoSmithKline (GSK) purchased 1,000 HumanHap550 BeadChips from Illumina. The agreement also includes the addition of a statement of work to utilize Illumina’s Fast-Track Genotyping Service to process approximately 4,000 disease samples for pharmacogenetics application.

    By the end of 2006, Illumina will have genotyped more than 15,000 samples and reported nearly 3.5 billion genotypes to GSK. “This purchase follows shortly after GlaxoSmithKline expanded their initial scope of work for a multiyear, genotyping services agreement with Illumina, demonstrating their continued uptake of our technology,” said Jay Flatley, Illumina president and CEO.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?